2026 Mikael J. Pittet: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	99	736	676	18	17	208	56174
Medicine	99	8419	7911	116	113	210	56199

Overview

Mikael J. Pittet is affiliated with the University of Geneva in Switzerland. Their research primarily spans the fields of medicine, immunology and microbiology, and biochemistry, genetics and molecular biology. Within these domains, their focus includes immunology, oncology, molecular biology, pulmonary and respiratory medicine, and cancer research.

The scientist's work emphasizes topics related to cancer immunotherapy and biomarkers, immune cells in cancer, immunotherapy and immune responses, immune cell function and interaction, single-cell and spatial transcriptomics, CAR-T cell therapy research, and epigenetics and DNA methylation.

Frequent co-authors in their publications include Ralph Weissleder, Rakesh K. Jain, Sara I. Pai, Olivier Michielin, and Dan G. Duda. Their research contributions are often published in venues such as bioRxiv (Cold Spring Harbor Laboratory), Immunity, Cell, Clinical Cancer Research, and Cancer Cell.

Some of the recent papers authored or co-authored by Mikael J. Pittet are:

Clinical relevance of tumour-associated macrophages (2022), Nature Reviews Clinical Oncology
CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers (2023), Science
COVID-19 diagnostics in context (2020), Science Translational Medicine
CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment (2021), Cell
A neutrophil response linked to tumor control in immunotherapy (2023), Cell

Best Publications

Understanding the tumor immune microenvironment (TIME) for effective therapy.

Mikhail Binnewies;Edward W. Roberts;Kelly Kersten;Vincent Chan

5622
Citations
Imaging in the era of molecular oncology

Ralph Weissleder;Mikael J. Pittet

2801
Citations
The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions

Matthias Nahrendorf;Filip K. Swirski;Elena Aikawa;Lars Stangenberg

2683
Citations
Identification of splenic reservoir monocytes and their deployment to inflammatory sites

Filip K. Swirski;Matthias Nahrendorf;Martin Etzrodt;Martin Etzrodt;Moritz Wildgruber

2600
Citations
The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide

Sophie Viaud;Sophie Viaud;Fabiana Saccheri;Grégoire Mignot;Takahiro Yamazaki

2187
Citations
Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata

Filip K. Swirski;Peter Libby;Elena Aikawa;Pilar Alcaide

1472
Citations
Single-Cell Transcriptomics of Human and Mouse Lung Cancers Reveals Conserved Myeloid Populations across Individuals and Species.

Rapolas Zilionis;Rapolas Zilionis;Camilla Engblom;Christina Pfirschke;Virginia Savova

1432
Citations
Myocardial infarction accelerates atherosclerosis

Partha Dutta;Gabriel Courties;Ying Wei;Florian Leuschner;Florian Leuschner

1190
Citations
Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

Antonella Sistigu;Takahiro Yamazaki;Erika Vacchelli;Kariman Chaba

1122
Citations
Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivo

Mei Ling Chen;Mikaël J. Pittet;Leonid Gorelik;Leonid Gorelik;Richard A. Flavell

1103
Citations
The spleen in local and systemic regulation of immunity

Vincenzo Bronte;Mikael J. Pittet

1087
Citations
TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy.

Christopher B. Rodell;Sean P. Arlauckas;Michael F. Cuccarese;Christopher S. Garris

1037
Citations
Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy

Christina Pfirschke;Camilla Engblom;Steffen Rickelt;Virna Cortez-Retamozo

965
Citations
Monocytes: Protagonists of Infarct Inflammation and Repair After Myocardial Infarction

Matthias Nahrendorf;Mikael J. Pittet;Filip K. Swirski

950
Citations
Therapeutic siRNA silencing in inflammatory monocytes in mice

Florian Leuschner;Partha Dutta;Rostic Gorbatov;Tatiana I Novobrantseva

937
Citations
Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12.

Christopher S. Garris;Sean P. Arlauckas;Rainer H. Kohler;Marcel P. Trefny

928
Citations
Clinical relevance of tumour-associated macrophages

Unknown

876
Citations
Imaging macrophages with nanoparticles

Ralph Weissleder;Matthias Nahrendorf;Mikael J. Pittet

873
Citations
The role of myeloid cells in cancer therapies

Camilla Engblom;Christina Pfirschke;Mikael J. Pittet

828
Citations
Origins of tumor-associated macrophages and neutrophils

Virna Cortez-Retamozo;Martin Etzrodt;Andita Newton;Philipp J. Rauch

774
Citations
Ex Vivo Staining of Metastatic Lymph Nodes by Class I Major Histocompatibility Complex Tetramers Reveals High Numbers of Antigen-experienced Tumor-specific Cytolytic T Lymphocytes

Pedro Romero;P. Rod Dunbar;Danila Valmori;Mikaël Pittet

644
Citations

Frequent Co-Authors

Ralph Weissleder Harvard University

Filip K. Swirski Icahn School of Medicine at Mount Sinai

Matthias Nahrendorf Harvard University

Pedro Romero University of Lausanne

Jean-Charles Cerottini University of Lausanne

Daniel E. Speiser University of Lausanne

Danila Valmori University of Nantes

Alfred Zippelius University Hospital of Basel

Philippe Guillaume University of Lausanne

Peter Libby Brigham and Women's Hospital

External Links

Wikipedia of Mikael J. Pittet Personal website of Mikael J. Pittet

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

Pursuing a career in immunology often intersects with healthcare professions that require specialized education and training. For those interested in expanding their knowledge and advancing their careers, understanding the available online degree options is essential.

Nurses looking to accelerate their path can explore nurse practitioner accelerated program options. These programs offer an efficient route to becoming a nurse practitioner, blending rigorous coursework with clinical experience.

Individuals without a nursing background may consider online ABSN programs for non nurses. These accelerated programs help non-nurses transition quickly into the nursing field, opening doors to immunology-related roles.

For those seeking shorter commitments, 12-month accelerated nursing programs provide a streamlined path to earning a Bachelor of Science in Nursing. These programs emphasize flexibility and speed without sacrificing quality.

Additionally, exploring the fastest and easiest LPN programs can be ideal for entry-level healthcare careers. Licensed Practical Nurses often support immunology research and clinical care under supervision.

Each pathway offers unique advantages depending on your career goals in immunology and healthcare, making online learning a practical option to gain relevant expertise efficiently.